The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. (Q53528346)
Jump to navigation
Jump to search
scientific article published on 20 July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. |
scientific article published on 20 July 2006 |
Statements
The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. (English)
Jeffrey Rhyne
Michael J Ryan
Charles White
Theodore Chimonas
Michael Miller
20 July 2006
84
8
647-650
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference